VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Prevention therapy
Preclinical
Small molecule
N
National Cheng-Kung University Hospital
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Cardiac Dysfunction
Unknown status
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Cardiac Dysfunction
Preclinical
Unknown status
Clinical
Trials by Indication
[1]
Cardiac Dysfunction
1 trial
Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction
Unknown status
·
N
National Cheng-Kung University Hospital
·
N/A
·
NCT05892146
·
100 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Prevention therapy. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Prevention therapy compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Prevention therapy. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
National Cheng-Kung University Hospital company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
N
National Cheng-Kung University Hospital
Related News